methoxyhydroxyphenylglycol has been researched along with guanabenz in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, RW; Marshall, WS; Snoddy, HD | 1 |
| Akutsu, M; Jin, EZ; Kakinoki, S; Katoh, K; Kitabatake, A; Nomura, A; Shimono, H; Takechi, S | 1 |
2 other study(ies) available for methoxyhydroxyphenylglycol and guanabenz
| Article | Year |
|---|---|
Lowering of rat brain 3-methoxy-4-hydroxyphenylethylene glycol sulphate (MOPEG sulphate) concentration by 2,6-dichlorobenzylidene aminoguanidine.
Topics: Animals; Brain Chemistry; Depression, Chemical; Guanabenz; Guanidines; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Time Factors | 1977 |
Recovery of cardiac norepinephrine concentration and tyrosine hydroxylase activity by the central alpha2-adrenoceptor agonist guanabenz in rats with aortic constriction.
Topics: Adrenal Glands; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Body Weight; Constriction; Guanabenz; Heart; Heart Ventricles; Hypertrophy, Left Ventricular; Kidney; Liver; Male; Methoxyhydroxyphenylglycol; Myocardium; Norepinephrine; Organ Size; Rats; Rats, Wistar; Spleen; Tyrosine 3-Monooxygenase; Vas Deferens | 1999 |